Dr. Kochenderfer is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
2013 Jefferson St SW
Fl 2
Roanoke, VA 24014Phone+1 540-586-5770Fax+1 540-586-3552
Education & Training
Wake Forest University Baptist Medical CenterFellowship, Hematology and Medical Oncology, 2002 - 2005- Wake Forest University Baptist Medical CenterResidency, Internal Medicine, 1999 - 2002
West Virginia University School of MedicineClass of 1999
Certifications & Licensure
VA State Medical License 2008 - 2026
NC State Medical License 1999 - 2009- American Board of Internal Medicine Hematology
- American Board of Internal Medicine Medical Oncology
Clinical Trials
- Study of Imprime PGG® in Combination With Cetuximab in Subjects With Recurrent or Progressive KRAS Wild Type Colorectal Cancer Start of enrollment: 2011 Apr 01
- BKM120 for Patients With PI3K-activated Tumors Start of enrollment: 2013 Mar 29
- Phase 2b Study of GC4711 in Combination With SBRT for Nonmetastatic Pancreatic Cancer Start of enrollment: 2021 May 07
- Join now to see all
Publications & Presentations
PubMed
- 7 citationsModified FOLFOX6 plus bevacizumab with and without nivolumab for first-line treatment of metastatic colorectal cancer: phase 2 results from the CheckMate 9X8 randomize...Heinz-Josef Lenz, Aparna Parikh, David R Spigel, Allen L Cohn, Takayuki Yoshino
Journal for Immunotherapy of Cancer. 2024-03-13 - 32 citationsA Randomized, Phase II Trial of Cetuximab With or Without PX-866, an Irreversible Oral Phosphatidylinositol 3-Kinase Inhibitor, in Patients With Metastatic Colorectal ...Daniel W. Bowles, Mark D. Kochenderfer, Allen Lee Cohn, Lucas Sideris, Nghia Nguyen
Clinical Colorectal Cancer. 2016-12-01 - 45 citationsSafety and Efficacy of Nivolumab in Patients With Advanced Non-Clear Cell Renal Cell Carcinoma: Results From the Phase IIIb/IV CheckMate 374 Study.Nicholas J Vogelzang, Mark R Olsen, Joshua J McFarlane, Edward Arrowsmith, Todd M Bauer
Clinical Genitourinary Cancer. 2020-12-01
Professional Memberships
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
